Mathematical modelling of Pseudomonas aeruginosa biofilm growth and treatment in the cystic fibrosis lung

Mathematical Medicine and Biology

Volumn 31, Issue 2, 2014, Pages 179-204

  Miller, J K ^a   Brantner, Justin S ^a   Clemons, Curtis ^a,b   Kreider, K L ^a,b   Milsted, Amy ^a   Wilber, Pat ^a,b   Yun, Yang H ^a,b   Youngs, Wiley J ^a   Young, Gerald ^a,b   Badawy, Hope T ^a   Wagers, Patrick O ^a  

^a UNIVERSITY OF AKRON   (United States)

^b The University of Akron   (United States)

Author keywords

Biofilm; Cystic fibrosis; Mathematical modelling; Nanoparticle; Pseudomonas aeruginosa; Silver carbene complex

Indexed keywords

BACTERIA; BIODEGRADABLE POLYMERS; BIOFILMS; DEGRADATION; PATIENT TREATMENT; SILVER COMPOUNDS;

BACTERIAL INFECTIONS; BIOFILM GROWTH; CARBENE COMPLEXES; CAUSES OF DEATH; CYSTIC FIBROSIS; FLOW CELLS; MATHEMATICAL MODELING; PSEUDOMONAS AERUGINOSA; SILVER CARBENE COMPLEX; SILVER CARBENES;

BIOLOGICAL ORGANS;

SILVER;

BIOFILM; BIOLOGICAL MODEL; COMPLICATION; COMPUTER SIMULATION; CONFOCAL MICROSCOPY; CYSTIC FIBROSIS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; IN VITRO STUDY; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; ULTRASTRUCTURE;

BIOFILMS; COMPUTER SIMULATION; CYSTIC FIBROSIS; HUMANS; IN VITRO TECHNIQUES; MICROSCOPY, CONFOCAL; MODELS, IMMUNOLOGICAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SILVER; SPUTUM;

EID: 84902588830     PISSN: 14778599     EISSN: 14778602     Source Type: Journal    
DOI: 10.1093/imammb/dqt003     Document Type: Article

References (81)

1. Alhede, M., Kragh, K., Qvortrup, K., Allesen-Holm, M., Gennip, M. V., Christensen, L., Jensen, P., Nielsen, A., Parsek, M., Wozniak, D., Molin, S., Tolker-Nielsen, T., Høiby, N., Givskov, M. & Bjarnsholt, T. (2011) Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLOS One, 6, 1-12.
2. Alpkvist, E. & Klapper, I. (2007) A multidimensional multispecies continuum model for heterogeneous biofilm development. B. Math. Biol., 69, 765-789.
3. Alkpvist, E., Overgaard, N., Gustafsson, S. & Heyden, A. (2004) A new mathematical model for chemotatic bacterial colony growth. Water, 49, 187-192.
4. Anderson, G. G., Moreau-Marquis, S., Stanton, B. A. & O'Toole, G. A. (2008) In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect. Immun., 76, 1423-1433.
5. Anguige, K., King, J. R. & Ward, J. P. (2006) A multi-phase mathematical model of quorum sensing in a maturing Pseudomonas aeruginosa biofilm. Math. Biosci., 203, 240-276.
6. Beyenal, H., Chen, S. & Lewandowski, Z. (2003) The double substrate growth kinetics of Pseudomonas aeruginosa. Enzyme Microb. Technol., 32, 92-98.
7. Bigger, J. (1944) Treatment of staphylococcal infections with penicillin. Lancet, 244, 497-500.
8. Bjarnsholt, T., Østrup Jensen, P., Fiandaca, M. J., Pedersen, J., Rønne Hansen, C., Bøgelund Andersen, C., Pressler, T., Givskov, M. & Høiby, N. (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol, 44, 547-558.
9. Boucher, R. C. (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur. Respir. J., 23, 146-158.
10. Carnoy, C., Ramphal, R., Scharfman, A., Lo-Guidice, J., Houdret, N., Klein, A., Galabert, C., Lamblin, G. & Roussel, P. (1993) Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa. Am. J. Resp. Cell Mol., 9, 323-334.
11. Carterson, A. J., Höner zu Bentrup, K., Ott, C. M., Clarke, M. S., Pierson, D. L., Vanderburg, C. R., Buchanan, K. L., Nickerson, C. A. & Schurr, M. J. (2005) A549 lung epithelial cells grown as threedimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect. Immun., 73, 1129-1140.
12. Chambless, J. D., Hunt, S.M. & Stewart, P. S. (2006) A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials. Appl. Environ. Microb., 72, 2005-2013.
13. Cogan, N. G. (2004) The role of the biofilm matrix in structural development. Math. Med. Biol., 21, 147-166.
14. Cogan, N. G. (2006) Effects of persister formation on bacterial response to dosing. J. Theor. Biol., 238, 694-703.
15. Cogan, N. (2010) An extension of the boundary integral method applied to periodic disinfection of a dynamic biofilm. SIAM J. Appl. Math., 70, 2281-2307.
16. Cogan, N., Cortez, R. & Fauci, L. (2005a) Modeling physiological resistance in bacterial biofilms. B. Math. Biol., 67, 831-853.
17. Cogan, N. G., Cortez, R. & Fauci, L. (2005b) Modeling physiological resistance in bacterial biofilms. B. Math. Biol., 67, 831-853.
18. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. (1999) Bacterial biofilms: a common cause of persistent infections. Science, 284, 1318-1322.
19. Ditto, A., Shah, P., Lopina, S. & Yun, Y. (2009) Nanospheres formulated from l-tyrosine polyphosphate as a potential intracellular delivery device. Int. J. Pharm., 368, 199-206.
20. Dodds, M., Grobe, K. & Stewart, P. (2000) Modeling biofilm antimicrobial resistance. Biotechnol. Bioeng., 68, 456-465.
21. Gabor, F., Bogner, E., Weissenboeck, A. & Wirth, M. (2004) The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv. Drug Deliver. Rev., 56, 459-480.
22. Gibson, R., Burns, J. & Ramsey, B. (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Resp. Crit. Care, 168, 918-951.
23. Gupta, A. S. & Lopina, S. T. (2002) L-tyrosine-based backbone-modified poly(amino acids). J. Biomat. Sci-Polym E., 13, 1093-1104.
24. Harmsen, M., Yang, L., Pamp, S. & Tolker-Nielsen, T. (2010) An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol. Med. Mic., 59, 253-268.
25. Harrison, F. (2007) Microbial ecology of the cystic fibrosis lung. Microbiology, 153, 917-923.
26. Häußler, S., Ziegler, I., Löttel, A., Götz, F., Rohde, M., Wehmhöhner, D., Saravanamuthu, S., Tümmler, B. & Steinmetz, I. (2003) Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J. Med. Microbiol., 52, 295-301.
27. Hentzer, M., Teitzel, G., Balzer, G., Heydorn, A., Molin, S., Givskov, M. & Parsek, M. (2001) Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol., 183, 5395-5401.
28. Heydorn, A., Ersbøll, B. K., Hentzer, M., Parsek, M. R., Givskov, M. & Molin, S. (2000a) Experimental reproducibility in flow-chamber biofilms. Microbiology, 146, 2409-2416.
29. Heydorn, A., Nielsen, A. T., Hentzer, M., Sternberg, C., Givskov, M., Ersbøll, B. K. & Molin, S. (2000b) Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology, 146, 2395-2407.
30. Hindi, K., Ditto, A., Panzner, M., Medvetz, D., Han, D., Hovis, C., Hilliard, J., Taylor, J., Yun, Y., Cannon, C. & Youngs, W. (2009) The antimicrobial efficacy of sustained release silver-carbene complexloaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. Biomaterials, 30, 3771-3779.
31. Høiby, N., Ciofu, O. & Bjarnsholt, T. (2010) Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol., 5, 1663-1674.
32. Hopfenberg, H. (1976) Controlled release from erodible slabs, cylinders, and spheres. Controlled Release Polymeric Formulations, Chapter 3 (D. Paul & F. Haris eds). Washington D.C.: American Chemical Society, pp. 26-32.
33. Kascatan-Nebioglu, A., Panzner, M., Tessier, C., Cannon, C. & Youngs, W. (2007) N-heterocyclic carbenesilver complexes: a new class of antibiotics. Coordin. Chem. Rev., 251, 884-895.
34. Klapper, I. (2004) Effects of heterogeneous structure in mechanically unstressed biofilms on overall growth. B. Math. Biol., 66, 809-824.
35. Klapper, I. & Dockery, J. (2010) Mathematical description of microbial biofilms. SIAM Rev., 52, 221-265.
36. Lambiase, A., Raia, V., Pezzo, M., Sepe, A., Carnovale, V. & Rossano, F. (2006) Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect. Dis., 6, 1-7.
37. Lardon, L., Merkey, B., Martins, S., Dötsch, A., Picioreanu, C., Kreft, J. & Smets, B. (2011) iDynoMiCS: next-generation individual-based modelling of biofilms. Environ. Microbiol., 13, 2416-2434.
38. Leid, J. G., Ditto, A. J., Knapp, A., Shah, P. N., Wright, B. D., Blust, R., Christensen, L., Clemons, C. B., Wilber, J. P., Young, G. W., Kang, A. G., Panzner, M. J., Cannon, C. L., Yun, Y. H., Youngs, W. J., Seckinger, N. M. & Cope, E. K. (2012) In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. J. Antimicrob. Chemoth., 67, 138-148. http://jac.oxfordjournals.org/content/early/2011/10/03/jac.dkr408.abstra ct.
39. Lewis, K. (2010) Persister cells. Annu. Rev. Microbiol., 64, 357-372.
40. Luna, E., Domínguez-Zacarias, G., Ferreira, C. P. & Velasco-Hernandez, J. X. (2004) Detachment and diffusive-convective transport in an evolving heterogeneous two-dimensional biofilm hybrid model. Phys. Rev. E, 70.
41. Miller, J. (2012) Mathematical modeling of Pseudomonas aeruginosa biofilm growth and treatment in the cystic fibrosis lung, Ph.D. Dissertation, University of Akron.
42. Miller, J., Badawy, H., Clemons, C., Kreider, K., Wilber, P., Milsted, A. & Young, G. (2012) Development of the Pseudomonas aeruginosa mushroom morphology and cavity formation by iron-starvation: a mathematical modeling study. J. Theor. Biol., 308, 68-78.
43. Miller, J., Neubig, R., Clemons, C., Kreider, K., Wilber, J., Young, G., Ditto, A. J., Yun, Y., Milsted, A., Baday, H., Panzner, M., Youngs, W. & Cannon, C. (2013) Nanoparticle deposition onto biofilms. Ann. Biomed. Eng., 41, 53-67.
44. Möker, N., Dean, C. & Tao, J. (2010) Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J. Bacteriol., 192, 1946-1955.
45. Moreau-Marquis, S., Bomberger, J., Anderson, G., Swiatecka-Urban, A., Ye, S., O'Toole, G. & Stanton, B. (2008) The ΔF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am. J. Physiol.-Lung C, 295, 25-37.
46. Moreau-Marquis, S., O'Toole, G. & Stanton, B. (2009) Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am. J. Resp. Cell Mol., 41, 305-313.
47. Mulcahy, H., Charron-Mazenod, L. & Lewenza, S. (2008) Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLOS Pathog., 4, 1-12.
48. Palmer, K., Aye, L. & Whiteley, M. (2007) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol., 189, 8079-8087.
49. Palmer, K. L., Mashburn, L. M., Singh, P. K. & Whiteley, M. (2005) Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol., 187, 5267-5277.
50. Panzner, M., Deeraksa, A., Smith, A., Wright, B., Hindi, K., Kascatan-Nebioglu, A., Torres, A., Judy, B., Hovis, C., Hilliard, J., Mallett, R., Cope, E., Estes, M., Cannon, C., Leid, J. & Youngs, W. (2009) Synthesis and in vitro efficacy of silver carbene complexes on biosafety level 3 bacteria. Eur. J. Inorg. Chem., 13, 1739-1745.
51. Picioreanu, C., Kreft, J., Klausen, M., Haagensen, J., Tolker-Nielsen, T. & Molin, S. (2007) Microbial motility involvement in biofilm structure formation-a 3D modelling study. Water, 55, 337-343.
52. Picioreanu, C., Kreft, J.-U. & van Loosdrecht, M. C. M. (2004) Particle-based multidimensional multispecies biofilm model. Appl. Environ. Microb., 70, 3024-3040.
53. Ramsey, B. (1996) Drug therapy-management of pulmonary disease in patients with cystic fibrosis. New Engl. J. Med., 335, 179-188.
54. Roberts, M. E. & Stewart, P. S. (2004) Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation. Antimicrob. Agents Ch., 48, 48-52. http://aac.asm.org/content/48/1/48.abstract.
55. Shafahi, M. & Vafai, K. (2010) Synthesis of biofilm resistance characteristics against antibiotics. Int. J. Heat Mass Transf., 53, 2943-2950. http://www.sciencedirect.com/science/article/pii/S0017931010001882.
56. Shah, D., Zhang, Z., Khodursky, A., Kaldalu, N., Kurg, K. & Lewis, K. (2006) Persisters: a distinct physiological state of E. coli. BMC Microbiol., 6, 53-61.
57. Singh, P. K., Shaefer, A. L., Parsek, M. R.,Moninger, T. O., Welsh, M. J. & Greenberg, E. P. (2000) Quorumsensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature, 407, 762-764.
58. Spoering, A. & Lewis, K. (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol., 183, 6746-6751.
59. Stewart, P. S., Hamilton, M. A., Goldstein, B. R. & Schneider, B. T. (1996) Modeling biocide action against biofilms. Biotechnol. Bioeng., 49, 445-455. http://dx.doi.org/10.1002/(SICI)1097-0290(19960220)49:4<445::AID-BIT1 2>3.0.CO;2-9.
60. Stine, A., Nassar, D., Miller, J., Clemons, C., Wilber, J., Young, G., Yun, Y., Cannon, C., Leid, J. G., Youngs,W. & Milsted, A. (2012) Modeling the response of a biofilm to silver-based antimicrobial. Math. Biosci., submitted.
61. Strathmann, M., Wingender, J. & Flemming, H. (2002) Application of fluorescently labelled lectins for the visualization and biochemical characterization of polysaccharides in biofilms of Pseudomonas aeruginosa. J. Microbiol. Methods, 50, 237-248.
62. Suh, J., Choy, K., Lai, S., Suk, J., Tang, B., Prabhu, S. & Hanes, J. (2007) PEGylation of nanoparticles improves their cytoplasmic transport. Int. J. Nanomed., 2, 1-7.
63. Suk, J., Lai, S., Wang, Y., Ensign, L., Zeitlin, P., Boyle, M. & Hanes, J. (2009) The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials, 30, 2591-2597.
64. Szomolay, B., Klapper, I., Dockery, J. & Stewart, P. S. (2005) Adaptive responses to antimicrobial agents in biofilms. Environ. Microbiol., 7, 1186-1191.
65. Tang, B., Dawson, M., Lai, S., Wang, Y., Suk, J., Yang, M., Zeitlin, P., Boyle, M., Fu, J. & Hanes, J. (2009) Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. PNAS, 106, 19268-19273.
66. Thurman, R. & Gerba, C. (1989) The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses. Crit. Rev. Environ. Control, 18, 295-315.
67. Tolker-Nielsen, T. & Sternberg, C. (2011) Growing and analyzing biofilms in flow chambers. Curr. Protoc. Microbiol., 21, 1B.2.1-1B.2.17.
68. Vrany, J., Stewart, P. & Suci, P. (1997) Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa biofilms displaying rapid-transport characteristics. Antimicrob. Agents Ch., 41, 1352-1358.
69. Wang, Y., Lai, S., Suk, J., Pace, A., Cone, R. & Hanes, J. (2008) Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that 'slip' through the human mucus barrier. Angew. Chem. Int. Edit., 47, 9726-9729.
70. Wang, Q. & Zhang, T. Y. (2010) Review of mathematical models for biofilms. Solid State Commun., 150, 1009-1022.
71. Wang, Q. & Zhang, T. (2012) Kinetic theories for biofilms. Discrete Cont. Dyn-B, 17, 1027-1059.
72. Wanner, O. & Gujer, W. (1986) A multispecies biofilm model. Biotechnol. Bioeng., 28, 314-328.
73. Wanner, O. & Reichert, P. (1996) Mathematical modeling of mixed-culture biofilms. Biotechnol. Bioeng., 49, 172-184.
74. Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., Botzenhart, K., Yankaskas, J. R., Randell, S., Boucher, R. C. & Döring, G. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest., 109, 317-325.
75. Xavier, J. B., Picioreanu, C., Rani, S. A., van Loosdrecht, M. C. M. & Stewart, P. S. (2005) Biofilm-control strategies based on enzymic disruption of the extracellular polymeric substance matrix-a modeling study. Microbiology, 151, 3817-3832.
76. Yang, L., Barken, K., Skindersoe, M., Christensen, A., Givskov, M. & Tolker-Nielsen, T. (2007) Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiology, 153, 1318-1328.
77. Yoon, S., Hennigan, R., Hilliard, G., Ochsner, U., Parvatiyar, K., Kamani, M., Allen, H., DeKievit, T., Gardner, P., Schwab, U., Row, J., Iglewski, B., McDermott, T., Mason, R.,Wozniak, D., Hancock, R., Parsek, M., Noah, T., Boucher, R. & Hassett, D. (2002) Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell, 3, 593-603.
78. Youngs, W., Tessier, C., Garrison, J., Quezada, C., Melaiye, A., Durmus, S., Panzner, M. & Kascatan-Nebioglu, A. (2005) Medicinal applications of metal complexes of n-heterocyclic carbenes. Medicinal Inorganic Chemistry (Doctrow S, McMurry T, Sessler J, and Lippard S, ed.), vol. 903, pp. 414-427.
79. Yu, H. & Head, N. E. (2002) Persistent infections and immunity in cystic fibrosis. Front. Biosci., 7, 442-457.
80. Zhang, T., Cogan, N. & Wang, Q. (2008a) Phase field models for biofilms. I. Theory and one-dimensional simulations. SIAM J. Appl. Math., 69, 641-669.
81. Zhang, T., Cogan, N. & Wang, Q. (2008b) Phase-field models for biofilms II. 2-D numerical simulations of biofilm-flow interaction. Commun. Comput. Phys., 4, 72-101.